Wafa Hassen

Title: Wafa Hassen: Innovator in Multiple Myeloma Research

Introduction

Wafa Hassen is a prominent inventor based in Montpellier, France. She has made significant contributions to the field of medical research, particularly in the area of multiple myeloma. Her innovative work has led to the development of a patented method that aids in predicting the prognosis of individuals suffering from this complex disease.

Latest Patents

Wafa Hassen holds a patent titled "Methods for the in vitro determination of the outcome and for the treatment of individuals having multiple myeloma." This patent describes a method for predicting the outcome of multiple myeloma patients by measuring the expression levels of specific genes. The process involves calculating an AOX score and/or a ROS score from the expression levels, which helps classify the individual's prognosis as either good or bad.

Career Highlights

Throughout her career, Wafa Hassen has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université de Montpellier. Her research has focused on understanding the molecular mechanisms underlying multiple myeloma, contributing to advancements in treatment strategies.

Collaborations

Wafa has collaborated with notable colleagues, including Alboukadel Kassambara and Jérôme Moreaux. These partnerships have enhanced her research efforts and expanded the impact of her work in the scientific community.

Conclusion

Wafa Hassen's innovative contributions to multiple myeloma research exemplify her dedication to improving patient outcomes. Her patented methods represent a significant advancement in the field, showcasing the importance of research and collaboration in medical science.